Wed.Jul 13, 2022

article thumbnail

Are digital pharmacies the answer?

World of DTC Marketing

Digital pharmacies seem to be springing up everywhere. Allowing patients to order medications online and get delivery via Fed-Ex or the mail does offer time savings. Still, without a significant value (lower costs), they may not find an audience. Using CVS.com, patients can order medications online and, for a small charge, even deliver them. It’s convenient for most but having a CVS pharmacy on almost every street corner allows patients to use drive-throughs to pick up their medications.

Doctors 245
article thumbnail

Solving the nursing crisis starts with psychological safety

MedCity News

When thinking about gratitude for nurses who have carried our nation over the last two-plus years, it’s going to take a lot more than a pizza party during Nurses Month to show them we care.

Safety 129
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Merck and Orion enter partnership to develop ODM-208 for prostate cancer

Pharmaceutical Technology

Merck (MSD outside North America) and Orion have entered an international agreement to develop and market the latter’s investigational candidate ODM-208 to treat metastatic castration-resistant prostate cancer (mCRPC). Under the deal, the companies will also develop various other drugs that act on cytochrome P450 11A1 (CYP11A1), an enzyme vital for steroid production.

article thumbnail

1 in 5 Americans received surprise bills despite law, many lack health insurance literacy, reports find

MedCity News

Skyrocketing medical bills and a lack of understanding in the healthcare system is putting financial stress on Americans in 2022, several recent reports have found. Despite the No Surprises Act, which protects consumers from surprise billing, many Americans said they’re still receiving unexpected bills, and a low healthcare literacy is making it difficult for them to know how to handle high medical bills, the surveys find.

Insurance 124
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

New York says Teva lied about role in opioid epidemic

pharmaphorum

New York’s attorney general has accused Teva of lying to evade responsibility for its alleged role in fuelling the opioid epidemic in the state and is asking for a case against the company to be reopened. AG Letitia James says the Israeli drugmaker “made significant and intentional misrepresentations” to her office and the court about its involvement with its US subsidiary in order to evade legal action and accountability.

article thumbnail

June was a good month for healthcare hiring, but the staffing crisis can only be solved by tech, VBC

MedCity News

Healthcare employment levels are still significantly below what they need to be, and they aren’t on track to get there any time soon. Experts are saying the increased deployment of technology, such as remote patient monitoring and robotic process automation, as well as value-based care models, will be the only sustainable solution to get providers out of this staffing dearth.

More Trending

article thumbnail

Monoclonal antibodies are the way out of the Covid-19 pandemic

MedCity News

Whether they are acting as a therapeutic or preventive treatment, monoclonal antibodies can allow us to help contain the virus, where we might see the light at the end of the tunnel.

Biopharma 121
article thumbnail

The power of the underdog: A rare disease nonprofit working to help patients win against the odds

PharmaVoice

Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

Patients 105
article thumbnail

Northwell pours $10M into Brightline as it, other providers aim to address pediatric mental health crisis

MedCity News

Brightline, a telehealth company that provides pediatric mental health care, received a $10 million investment from Northwell Health. The startup will use the funds to scale its platform, as well as pursue a strategic partnership in which Northwell’s patients receive in-network care on its platform.

article thumbnail

Woman of the Week: Kura Oncology's Kirsten Flowers

PharmaVoice

How the chief commercial and corporate strategy officer is embracing a ‘full-cup’ philosophy to build a better leadership toolbox.

98
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Merck strikes a $290M deal for novel prostate cancer drug

MedCity News

Merck is partnering with Orion on the clinical development and potential commercialization of a new drug for advanced prostate cancer. Though Merck already has a piece of the prostate cancer drug market, Orion’s drug would offer a new approach for treating cancers that have become resistant to currently available hormone therapies.

Marketing 104
article thumbnail

Nipah virus vaccine enters Phase I trial

European Pharmaceutical Review

The US National Institute of Allergy and Infectious Diseases (NIAID) has launched a Phase I clinical trial to evaluate a messenger RNA (mRNA) vaccine developed to prevent infection with Nipah virus. Nipah virus infection is a zoonotic disease (ie, it spreads between animals and people) and fruit bats are its natural host. The first known Nipah outbreak occurred in 1998 in Malaysia and Singapore and resulted in 265 human cases and 105 deaths.

Safety 81
article thumbnail

CMS’s newly released Remote Therapeutic Monitoring codes allow providers to bill for digital health, but only if payers adopt them

MedCity News

In addition to helping providers meet consumer expectations, remote therapeutic monitoring can serve to augment and de-load overburdened practices while also opening new revenue streams.

98
article thumbnail

Advancing cell therapies – ?? T cells and the combination factor

European Pharmaceutical Review

Please give some background on TC BioPharm and its aims. Kobel: As the global leader in allogeneic gamma delta (??) T-cell technologies, we are focused on the use of our platform allogeneic ?? T cells from healthy donors as a therapeutic for oncology indications. Right now, we are targeting blood cancers, with clinical data in relapsed/refractory acute myeloid leukaemia (AML), and moving into solid tumours, most likely in some version of a combination therapy or as a modified ??

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Cancer care poses challenges for employers; Transcarent shares vision for how it can help [Sponsored]

MedCity News

As they seek to support their staff, self-insured employers are turning to innovative programs to balance evidence based programs with the need to manage healthcare costs.

article thumbnail

Afrigen to collaborate with NIAID on mRNA vaccine research

European Pharmaceutical Review

Afrigen Biologics and the US National Institute of Allergy and Infectious Diseases (NIAID) have agreed to share technical expertise related to the development of next-generation messenger RNA (mRNA) vaccines and therapeutics. . “The pursuit of effective vaccines for human diseases to improve public health is central to the mission of the NIAID Vaccine Research Center.

article thumbnail

New York AG: Teva USA’s parent company shouldn’t be allowed to escape opioid liability

MedCity News

Without the parent company, there’s concern Teva won’t be able to pay billions in reward to NY state.

article thumbnail

A Textbook Life, By An Author

Copyright Clearance Center

The post A Textbook Life, By An Author appeared first on Copyright Clearance Center.

98
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Memory Health CEO shares approach to combating Alzheimer’s disease

MedCity News

Memory Health CEO Edward Shehab talked about taking a preventive approach to neurodegenerative conditions.

98
article thumbnail

A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS

Pharmatutor

A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS. About Authors. Ms. Priti B. Savant,Ms. Ashwini R. Pawar, Ms. Kaufiya D. Sayyed , Ms. Pooja R. Yelmar. 1,2,3,4 Sahyadri College of Pharmacy Methwade Tal, Sangola, Distsolapur Maharashtra 413307. admin. Wed, 07/13/2022 - 15:34. Tags. Articles.

59
article thumbnail

Genentech expands immuno-oncology partnership with Bicycle Therapeutics

Pharmaceutical Technology

Roche Group member Genentech has expanded the exclusive strategic partnership agreement with Bicycle Therapeutics by exercising its second option to commence a new programme. The initial agreement was signed in February 2020 for discovering, developing and marketing new immuno-oncology therapies based on Bicycle’s bicyclic peptide technology. Under the deal, the companies are working on discovering and conducting pre-clinical development of new immunotherapies based on Bicycle technology against

article thumbnail

AstraZeneca partners Health2Sync on CKD digital support tool

pharmaphorum

Taiwan-based digital health firm Health2Sync has added another big pharma company to the roster of clients for its patient support platform. The latest partner is AstraZeneca, which has signed up with Health2Sync to develop a digital patient management programme for chronic kidney disease (CKD) patients in Taiwan. The digital health firm is also working with Sanofi, Novo Nordisk and Abbott on diabetes support tools, but this is its first project in the CKD arena.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Sell NFTs and Digital Products on MARKET

Verb

MARKET is a livestream shopping platform built to support sellers from all categories whether it’s fashion, food, fun, sports, beauty, and more! Recently, we announced that MARKET will now be supporting sellers with digital products, including NFTs. We’re excited about this new avenue for MARKET and the potential it has in the livestream selling industry.

article thumbnail

NHS leaders voice stark staff warning

PharmaTimes

Changes to vocational BTEC healthcare qualifications could see reduction in new nurse recruits

article thumbnail

Boosting Your B2B Healthcare Market Share

Scott’s Directories

The marketing language used these days often includes terminologies like B2B and B2C. While the latter means Business to Consumer and includes campaigns that directly target consumers, the former refers to Business to Business, which means B2B marketing focuses on strategies that help a business sell its products and services to another business. The B2B healthcare market, in particular, is extremely competitive.

article thumbnail

Accurate Determination of Mutagenic Azido, NDSRI, and Nitrosamine Impurities in Drug Substances and Products Using LC–MS/MS

PharmaTech

Thursday, July 14th, 2022 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Join us to learn approaches for the accurate determination of mutagenic azido, NDSRI, and nitrosamine impurities in drug substances and products using LC–MS/MS.

52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch® Ventricular Restoration System

Legacy MEDSearch

Ancora Heart , Inc., a company developing a novel device-based therapy to address heart failure, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch ® Ventricular Restoration System. Currently being evaluated in the CORCINCH-HF pivotal clinical trial, the AccuCinch System is designed to provide a minimally invasive treatment option for patients who have symptomatic heart failure (HF) with reduced ejection fraction (HFrEF).

article thumbnail

How to use data to achieve an effective promotional review process

Vodori

Getting advertising and promotional content to market quickly in support of product and campaign launches is essential for any life science organization. But your ability to get that content to market requires an effective and efficient promotional review process. The less effective your MLR review process, the more time consuming and frustrating it is for your promotional review committee.

article thumbnail

7 Ways to Create the Perfect Medical Device Marketing Strategy and Sales Plan

Medico Reach

In the 21 st century, with the advent of various marketing tactics, it can be rather overwhelming to draw up an effective marketing strategy. It’s an even more complicated space for the medical device market. After all, the medical devices industry has to tread the fine line between compliance and effectiveness. Therefore, drawing up a medical device marketing strategy can often become a hassle.

Medical 52
article thumbnail

Digitalization hiring levels in the pharmaceutical industry rose in June 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for digitalization related positions rose in June 2022 compared with the equivalent month last year, with 55.1% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 47.3% of companies who were hiring for digitalization related jobs a year ago but a decrease compared to the figure of 57.5% in May 2022.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.